Back to Weight Loss & Metabolic
NewTirzepatide 10mg lyophilized peptide vial — Healthy Aminos, ≥98% purity
Weight Loss & Metabolic

Tirzepatide Peptide

10mg · Lyophilized Powder · ≥98%

Tirzepatide is a 39-amino acid dual GIP/GLP-1 receptor agonist based on the native GIP sequence. It incorporates a C-20 fatty diacid moiety for albumin binding and includes amino acid substitutions enabling GLP-1R cross-reactivity while maintaining GIPR activity. Studied in the SURPASS and SURMOUNT clinical trial programs with over 15,000 participants. The SURPASS-2 trial is the only published head-to-head comparison with semaglutide.

Select Size

Batch Information

Batch ID
Purity≥98%
FormLyophilized powder
Storage-20°C, protect from light
Third-party COA verified · 6-point testing protocol
View COA →
$54.99
1
≥98% Purity Verified
Independent COA
Free Shipping $150+
Research Use Only

Tirzepatide

$54.99

Research Use Only

FOR RESEARCH USE ONLY. Products sold by Healthy Aminos are intended strictly for in-vitro research and laboratory use. Not for human or animal consumption. Not FDA approved. By purchasing from Healthy Aminos, the buyer acknowledges that these products are not intended to diagnose, treat, cure, or prevent any disease. All products are sold as reference standards and research chemicals only.

Loading COA data...

Compound Specifications

Molecular Weight4813.53 Da
Molecular FormulaC225H348N48O68
CAS Number2023788-19-2
Synonyms
HA-TRZ, LY3298176, Mounjaro compound
Research Applications
Dual incretin signalingMetabolic researchWeight managementGlycemic researchGIP/GLP-1 pathway

Research Context

Dual agonist targeting both GIP receptor (primary) and GLP-1 receptor (secondary). The dual mechanism engages complementary incretin pathways for glucose-dependent insulin secretion and metabolic regulation.

View published research

Tirzepatide Published Research

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. It represents a novel mechanism as the first dual incretin receptor agonist studied in large clinical trials. Its unique pharmacology combines activity at both GIP and GLP-1 receptors.

Dual Incretin Receptor Pharmacology

Published research has characterized tirzepatide's balanced agonism at both GIP and GLP-1 receptors. Studies have examined its receptor binding kinetics, biased agonism profile, and the contribution of each receptor pathway to observed effects. Research published in Cell Metabolism detailed its molecular design and dual-receptor activation mechanism.

References

Tirzepatide once weekly for the treatment of obesityN Engl J Med (2022). PMID: 34170647

Clinical Trial Programs

Tirzepatide has been studied in the SURPASS and SURMOUNT clinical trial programs. Research published in the New England Journal of Medicine examined dose-response relationships across 5mg, 10mg, and 15mg dose levels in controlled study populations. These trials are among the largest peptide clinical trials conducted to date.

The studies referenced above are presented for informational purposes only and do not constitute medical claims. All Healthy Aminos products are sold for research use only and are not intended for human consumption.

Frequently Asked Questions About Tirzepatide

What is Tirzepatide peptide?
Tirzepatide is a research-grade peptide available from Healthy Aminos. Tirzepatide is a 39-amino acid dual GIP/GLP-1 receptor agonist based on the native GIP sequence. It incorporates a C-20 fatty diacid moiety for albumin binding and includes amino acid substitutions enabling GLP-1R cross-reactivity while maintaining GIPR activity. Studied in the SURPASS and SURMOUNT clinical trial programs with over 15,000 participants. The SURPASS-2 trial is the only published head-to-head comparison with semaglutide. It is supplied in lyophilized (freeze-dried) form for laboratory research use only.
What purity is Healthy Aminos Tirzepatide?
Our Tirzepatide is verified at ≥98% purity via HPLC analysis. Each batch includes an independent third-party Certificate of Analysis (COA) with HPLC chromatogram and mass spectrometry confirmation.
How should I store Tirzepatide?
Tirzepatide should be stored at -20°C, protect from light for long-term storage or 2-8°C for short-term use. Keep sealed, away from light and moisture. Lyophilized peptides maintain stability for 24+ months when stored properly.
Does Healthy Aminos Tirzepatide come with a COA?
Yes. Every batch of Tirzepatide ships with a batch-specific Certificate of Analysis including HPLC purity, mass spectrometry confirmation, endotoxin testing, sterility testing, and peptide content verification.
What is the molecular weight of Tirzepatide?
Tirzepatide has a molecular weight of 4813.53 Da. Its molecular formula is C225H348N48O68.
Is Tirzepatide legal to purchase?
Tirzepatide is sold as a Research Use Only (RUO) chemical reference standard. It is legal to purchase in the United States for legitimate scientific research. It is not approved by the FDA for any diagnostic, therapeutic, or clinical purpose.

Related Weight Loss & Metabolic Peptides

Weight Loss & Metabolic
Popular
Semaglutide 10mg lyophilized peptide vial — Healthy Aminos

Semaglutide

10mg · Lyophilized powder

Semaglutide is a 31-amino acid GLP-1 receptor agonist based on the GLP-1(7-37) sequence with two key modifications: an Aib substitution at position 8 (protects against DPP-4 degradation) and a C-18 fatty diacid linker at position 26 (albumin binding for half-life extension). It has been studied in multiple large-scale clinical trial programs including SUSTAIN, PIONEER, and STEP, with over 20,000 total trial participants.

HA-SEMA-2026A
MW: 4113.58 Da
COA Verified · ≥98%
Weight Loss & Metabolic
Trending
Retatrutide 10mg lyophilized peptide vial — Healthy Aminos

Retatrutide

10mg · Lyophilized powder

Retatrutide is a triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously — the first peptide to engage all three pathways. Early phase clinical trial results published in the New England Journal of Medicine showed dose-dependent responses across metabolic parameters. The triple-agonist mechanism is a novel approach that goes beyond existing dual-agonist compounds.

HA-RETA-2026A
MW: 4603.28 Da
COA Verified · ≥98%

Research Use Only

FOR RESEARCH USE ONLY. Products sold by Healthy Aminos are intended strictly for in-vitro research and laboratory use. Not for human or animal consumption. Not FDA approved. By purchasing from Healthy Aminos, the buyer acknowledges that these products are not intended to diagnose, treat, cure, or prevent any disease. All products are sold as reference standards and research chemicals only.